M28 Capital Management LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
M28 Capital Management LP disclosed 9 US equity positions worth $137.6m in its Q4 2025 13F filing. The largest position was WVE at 70.0% of the reported book, followed by IVVD and TGTX. Against the Q3 2025 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 9 holdings.
What did M28 Capital Management LP own in Q4 2025? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 70.0% | $96.3m | 5,664,548 | 0% | held |
| 2 | IVVD INVIVYD INC | Healthcare | 16.6% | $22.8m | 9,248,250 | 0% | held |
| 3 | TGTX TG THERAPEUTICS INC | Healthcare | 3.5% | $4.8m | 161,600 | 0% | held |
| 4 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 3.3% | $4.5m | 67,400 | 0% | held |
| 5 | GUTS FRACTYL HEALTH INC | 3.0% | $4.1m | 1,856,117 | 0% | held | |
| 6 | PROQR THRAPEUTICS N V | 1.5% | $2.1m | 1,019,498 | 0% | held | |
| 7 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 1.0% | $1.4m | 385,680 | 0% | held |
| 8 | SLN SILENCE THERAPEUTICS PLC | 0.8% | $1.1m | 185,100 | 0% | held | |
| 9 | CRIS CURIS INC | 0.4% | $514.3k | 521,059 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.